United States Securities and Exchange Commission · EDGAR Accession 0002020332-26-000003

Form C-AR

Annual Report — Regulation Crowdfunding
Issuer CIK 2020332
Period 2025-12-31

32 Biosciences, Inc.

CorporationDEIncorporated 2023ILLINOIS, IL32biosciences.com
B

Financial Condition

two fiscal years, as filed
Pre-revenueBurn increasingDebt / assets 274%7 employees
Line itemMost recent FYPrior FYΔ
Revenue053,691▼ 100%
Cost of goods sold00
Net income(3,091,429)(1,742,797)▼ burn
Total assets2,091,4861,478,698▲ 41%
Cash & equivalents1,857,3111,183,699▲ 57%
Accounts receivable00
Short-term debt358,68114,917
Long-term debt5,378,2153,177,281▲ 69%
Taxes paid00

Figures in USD as reported by the issuer.